Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Immunopathol Pharmacol ; 25(1 Suppl): 35S-41S, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22652160

RESUMO

Antimuscarinic drugs are the first line pharmacotherapy for overactive bladder, but they are not always effective to achieve complete continence. Nevertheless in some patients urodynamic investigations reveal insufficient effects with continuing incontinence events even with dose optimization. The aim of this study is to evaluate the effect of association of Oxybutynin chloride, Trospium chloride and Solifenacin succinate administered orally for a minimum of 12 weeks in subjects with suprasacral spinal cord injury with urge-incontinence, urodynamic–proven neurogenic detrusor overactivity dysfunction and detrusor-external sphincter dyssynergia to improve level of continence, reduce the risks of urologic complications and enhance QOL. This study was a randomized, double blind, controlled, balanced-parallel-groups investigation of orally administed Oxybutynin in addition to Trospium chloride in the first group and Oxybutynin in addition to Solifenacin in the other group. A total of 12 patients with neurogenic detrusor overactivity and clean intermittent catheterization were allocated into two treatment groups: 5 mg tablet of Oxibutinin and 20 mg tablet of Trospium Chloride were administered respectively 3 times a day and 4 times a day in the first group (Group A). 5 mg tablet of Oxibutinin and 10 mg tablet of Solifenacin were administered respective 3 times a day and once daily in the second group (Group B). In both group of patients we found a significant decrease in incontinence episodes, with an improvement of bladder compliance, bladder capacity and volume voided. Side effects were higher in patients of group B, but in generally well tolerated. In conclusion, a combined antimuscarinic treatment might be a right option for patients affected by neurogenic bladder refractory to previous antimuscarinic monotherapy, and might slow down or delay other more invasive treatments.


Assuntos
Antagonistas Muscarínicos/administração & dosagem , Bexiga Urinaria Neurogênica/tratamento farmacológico , Bexiga Urinária Hiperativa/tratamento farmacológico , Adulto , Benzilatos/administração & dosagem , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Humanos , Masculino , Ácidos Mandélicos/administração & dosagem , Nortropanos/administração & dosagem , Quinuclidinas/administração & dosagem , Succinato de Solifenacina , Tetra-Hidroisoquinolinas/administração & dosagem , Bexiga Urinaria Neurogênica/fisiopatologia , Bexiga Urinária Hiperativa/fisiopatologia , Urodinâmica
2.
Funct Neurol ; 7(3): 223-5, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1500012

RESUMO

Twelve ataxic subjects (seven with Friedreich's heredo-ataxia and five with a cerebellar vascular or traumatic lesion) were examined by way of urodynamic evaluation. The results explain the role the cerebellum plays in the modulation of the micturition reflex and confirm the importance of bilateral encephalic damage in causing vesico-sphincteral malfunctioning and the important role of the lateral myelon cords in transporting bladder proprioceptive sensitivity.


Assuntos
Ataxia Cerebelar/fisiopatologia , Ataxia de Friedreich/fisiopatologia , Bexiga Urinaria Neurogênica/fisiopatologia , Urodinâmica/fisiologia , Adulto , Idoso , Ataxia Cerebelar/diagnóstico , Feminino , Ataxia de Friedreich/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Reflexo/fisiologia , Bexiga Urinária/fisiopatologia , Bexiga Urinaria Neurogênica/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA